Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. Bayer HealthCare LLC
CRL
•Bayer HealthCare LLC

Bayer HealthCare LLC – FDA CRL

Record Details

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Bayer HealthCare LLC for their New Drug Application (NDA 218506) concerning a Naproxen sodium capsule. The FDA determined the application cannot be approved in its current form due to several significant issues.

Key deficiencies include inadequate nonclinical data to support the application. Additionally, a pre-approval inspection of a manufacturing facility identified significant issues documented in an FDA Form 483, which adversely impact the facility's ability to perform its designated functions and affect product quality. The proposed proprietary name was conditionally acceptable but requires resubmission after all deficiencies are resolved, and comments on labeling are reserved pending resolution of other issues.

Under the FDA's regulatory framework for NDA review, Bayer HealthCare LLC must take several actions. They are required to provide adequate nonclinical data and ensure the inspected facility submits satisfactory responses to its Form 483 deficiencies, including these response dates in their resubmission. A comprehensive safety update, as per 21 CFR 314.50(d)(5)(vi)(b), is also mandated, encompassing all nonclinical and clinical study safety information, adverse event re-tabulations, and worldwide safety experience. Bayer must resubmit the complete application within one year, fully addressing all identified deficiencies, as the product cannot be legally marketed until formal approval. A meeting with the FDA can be requested to discuss these requirements.

Company
Bayer HealthCare LLC
Product type
NDA (New Drug Application)
Office
Center for Drug Evaluation and Research
Person
  • Oliwier Nowak
View Company Profile

ID · 47d81f27-90e6-43bd-a0e5-43f8e0e9cdf3

Other documents for Bayer HealthCare LLC
  • EIR - 2015-07-01July 1, 2015
  • 483 - 2015-06-30June 30, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bayer HealthCare LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.